medigraphic.com

2009, Number 1

<< Back Next >>

Cir Cir 2009; 77 (1)

Resultados con la aplicación de toxina botulínica en pacientes con endotropía y retraso psicomotor

Arroyo-Yllanes ME, Pérez-Pérez JF, Murillo-Murillo L

Language: Spanish
References: 40
Page: 9-12
PDF size: 85.76 Kb.


ABSTRACT

Objective: We undertook this study to evaluate the results of the treatment with botulinum toxin in patients with esotropia and psychomotor delay.
Methods: Patients with esotropia and delayed psychomotor development, in rehabilitation therapy and without previous surgery were included. A complete ophthalmological and strabismological exploration was performed including cycloplegic refraction with atropine 1%. Botulinum toxin was applied under sedation in both internal recti. Results were evaluated 1 week, 1 month, 3 and 6 months and after 1 year of application. The reinjection was decided if a 25 DP esotropia or greater was obtained before 3 months of the first application. A good result was considered in patients who had 10 DP of deviation and variability <10 DP.
Results: Thirty two patients were included. There were 14 were women and 18 men with an age range from 5 months to 5 years (average 16.8 months). Eighteen patients had variability in the angle of deviation from 20 to 45 DP of esotropia and 14 without variability with an average of 39.12 DP. Thirteen patients were reinjected. A good result was obtained in 10 patients, fair in 17 patients and poor in 5 patients due to persistence of variability in four cases and 15 DP hypertropia in one.
Conclusions: Application of botulinum toxin is a therapeutic alternative in patients with esotropia and psychomotor delay.


REFERENCES

  1. Lozano PA. Utilidad de la toxina botulínica en el tratamiento de los estrabismos. En: Murillo C. Temas selectos de estrabismo. Segunda edición. México: Centro Mexicano de Estrabismo; 2005. pp. 173-176.

  2. Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 1980;10:1044-1049.

  3. Jankovic J. Therapeutic uses of botulinum toxin. N Engl J Med 1991;324:1186-1194.

  4. Scott AB, Magoon EH, McNeer KW, Stager DR. Botulinum treatment of childhood strabismus. Ophthalmology 1990;97:1434-1438.

  5. 5.Mc Neer KW, Spencer RF, Tucker MG. Observations on bilateral simultaneous botulinum toxin injection in infantile esotropia. J Pediatr Ophthalmol Strabismus 1994;31:214-219.

  6. Mc Neer KW, Tucker MG, Spencer RF. Management of essential infantile esotropia with botulinum toxin A: review and recommendations. J Pediatr Ophthalmol Strabismus 2000;37:63-67.

  7. Gómez de Liaño-Sánchez R, Rodríguez-Sánchez JM, De Andrés ML, Gómez de Liaño-Sánchez P. Tratamiento del estrabismo convergente con cirugía o con toxina botulínica. Acta Estrabol 1996;22:1-2.

  8. Gómez de Liaño-Sánchez R, Rodríguez-Sánchez JM, De Andrés ML, Gómez de Liaño-Sánchez P. Tratamiento del estrabismo infantil mediante toxina botulínica. Acta Estrabol 1993;21:37-42.

  9. Gómez de Liaño-Sánchez P. Toxina botulínica en el tratamiento del estrabismo. Resultado sensorial y motor. Acta Estrabol 1995;24:183-188.

  10. Repka MX, Lam GC, Morrison NA. The efficacy of botulinum neurotoxin A for the treatment of complete and partially recovered chronic sixth nerve palsy. J Pediatr Ophthalmol Strabismus 1994;31:79-83.

  11. Moguel-Ancheita S, Martínez-Oropeza S, Orozco-Gómez LP. Aplicaciones de toxina botulínica en estrabismo. Rev Mex Oftalmol 1997;71:194-200.

  12. 12.Toledo R, Saucedo A. Resultado en endotropías no acomodativas tratadas con toxina botulínica. Rev Mex Oftalmol 2006;80:64-68.

  13. Moguel-Ancheita S. Tratamiento del estrabismo con toxina botulínica. Rev Mex Pediatr 2000;67:166-171.

  14. Campos EC, Schiavi C, Bellusci C. Critical age of botulinum toxin treatment in essential infantile esotropia. J Pediatr Ophthalmol Strabismus 2000;37:328-332.

  15. Horgan SE, Lee JP, Bunce C. The long-term use of botulinum toxin for adult strabismus. J Pediatr Ophthalmol Strabismus 1998;35:9-19.

  16. Mc Neer KW, Tucker MG, Guerry CH, Spencer RF. Incidence of stereopsis after treatment of infantile esotropia with botulinum toxin A. J Pediatr Ophthalmol Strabismus 2003;40:288-292.

  17. Hauviller V. Estrabismo en la afaquia infantil: su tratamiento con toxina botulínica. Memorias del XIII Congreso del Consejo Latinoamericano de Estrabismo. México: Consejo Latinoamericano de Estrabismo; 1997. pp. 96-98.

  18. Merino P, Gómez de Liaño P, García C, Bartolomé G, Rodríguez C, De Juan L. Parálisis bilateral del IV par y toxina botulínica. Arch Soc Español Oftalmol 2004;79:119-124.

  19. Carruthers J. The treatment of congenital nystagmus with botox. J Pediatr Ophthalmol Strabismus 1995;32:306-330.

  20. Ruiz-Guerrero M, Moreno-López M, Álvarez-García MT, García-de Arriba S, Núñez-Sánchez A, Rodríguez-Sánchez JM. Desviación vertical disociada y síndromes alfabéticos en la endotropía congénita tratada con toxina botulínica. Acta Estrabol 1997;16:1-6.

  21. Campomanes G. Tratamiento con toxina botulínica en endotropía congénita. Memorias del XIII Congreso del Consejo Latinoamericano de Estrabismo. México: Consejo Latinoamericano de Estrabismo; 1997. pp. 104-105.

  22. Moguel-Ancheita S, Dixon-Olvera S, Martínez-Oropeza S, Orozco-Gómez LP. Utilidad de la toxina botulínica en el tratamiento del estrabismo en enfermedades sistémicas. Arch Soc Esp Oftalmol 2003;78:9-14.

  23. Scott AB. Tratamiento del estrabismo con toxina botulínica. En: Actualidades del estrabismo latinoamericano. México: CIVA Visión; 1998. pp. 377-393.

  24. Duke-Elder S. System of Ophthalmology. Vol VI, Ocular Motility and Strabismus. Henry Kimpton; 1973. p. 611.

  25. Cüppers C. The so-called faden operation. In: Proceedings II Int. Congress of the Strabismological Association Marseilles. The International Strabismological Association, Marseille, France; 1976.

  26. Murillo-Murillo L, Ramírez-Barreto MA. Cirugía de la endotropía de ángulo variable con la operación de “faden” de Cüppers. An Soc Mex Oftalmol 1979;53:7-11.

  27. Mozo-Cueto A, Castellanos-Bracamontes A. Estrabismo no acomodativo de ángulo variable. Rev Mex Oftalmol 1990;64:9-13.

  28. Castellanos-Bracamontes A, Mozo-Cueto A. Estrabismos de ángulo variable y su relación con la mala visión y el retraso psicomotor. Bol Med Hosp Infant Mex 1990;47:820-832.

  29. 29.Trejo-Morán A, Arroyo-Yllanes ME, Jeppesen-Martínez E, Arroyo-Moreno JA. Endotropía de ángulo variable: factores etiopatogénicos. Rev Mex Oftalmol 1994;68:191-94.

  30. Moguel-Ancheita S, Martínez-Oropeza S, Orozco-Gómez LP. Tratamiento con toxina botulínica para estrabismo con retraso psicomotor. Arch Soc Esp Oftlamol 2004;79:443-448.

  31. Mwanza JC, Nkidiaka CM, Kayembe DL, Maillet CY, Mukau EJ, Tuela MR. Ophthalmologic abnormalities in mentally retarded. Bull Soc Belge Ophthalmol 2000;277:75-78.

  32. Arroyo-Yllanes ME, Manzo-Villalobos G, Pérez-Pérez JF, Garrido E. Strabismus in patients with cerebral palsy. Am Orthop J 1999;49:141-147.

  33. Becerril-Carmona AF, Arroyo-Yllanes ME, Paciuc-Beja M. Alterations of ocular motility in Down Syndrome. Am Orthop J 1997;47:181-188.

  34. 34.Tamura EE, Hoyt CS. Oculomotor consequences of intraventricular hemorrhages in premature infants. Arch Ophthalmol 1987;105:533-535.

  35. Holman RE, Merritt JC. Infantile esotropia: results in the neurologic impaired and “normal” child at NCMH (six years). J Pediatr Ophthalmol Strabismus 1986;23:41-45.

  36. Charles SJ, Moore AT. Results of early surgery for infantile esotropia in normal and neurologically impaired infants. Eye 1992;6:603-606.

  37. Habot-Wilner Z, Spierer A, Glovinsky J, Wygnanski-Jaffe T. Bilateral medial rectus muscle recession: results in children with developmental delay compared with normally developed children. J AAPOS 2006;10:150-154.

  38. Hauvellier V, Gamio S, Sors MV. Essential infantile esotropia in neurologically impaired pediatric patients: is botulinum toxin better primary treatment than surgery? Binocul Vis Strabismus Q 2007;22:221-226.

  39. 39.Tejedor J, Rodríguez JM. Management of nonresolving consecutive exotropia following botulinum toxin treatment of childhood esotropia. Arch Ophthalmol 2007;125:1210-1213.

  40. Cronemberger MF, Mendonça TS, Bicas HE. Botulinum toxin treatment for horizontal strabismus in children with cerebral palsy. Arq Bras Oftalmol 2006;69:523-529.




2020     |     www.medigraphic.com